Brinavess European Union - English - EMA (European Medicines Agency)

brinavess

correvio - vernakalant hydrochloride - atrial fibrillation - cardiac therapy - rapid conversion of recent onset atrial fibrillation to sinus rhythm in adults:for non-surgery patients: atrial fibrillation 

BRINAVESS 20 MGML Israel - English - Ministry of Health

brinavess 20 mgml

tzamal bio-pharma ltd - vernakalant hydrochloride - concentrate for solution for infusion - vernakalant hydrochloride 20 mg/ml - vernakalant - vernakalant - rapid conversion of recent onset atrial fibrillation to sinus rhythm in adults who are hemodynamically stable.- for non-surgery patients: atrial fibrillation ≤ 7 days duration- for post-cardiac surgery patients: atrial fibrillation ≤ 3 days duration

BRINAVESS SOLUTION Canada - English - Health Canada

brinavess solution

cipher pharmaceuticals inc - vernakalant hydrochloride - solution - 20mg - vernakalant hydrochloride 20mg - class iii antiarrythmics

BRINAVESS Concentrate for Solution for Infusion 20mg/ml Singapore - English - HSA (Health Sciences Authority)

brinavess concentrate for solution for infusion 20mg/ml

zuellig pharma pte. ltd. - vernakalant 18.1mg/ml equivalent vernakalant hydrochloride - infusion, solution concentrate - 20mg/ml

Brinavess New Zealand - English - Medsafe (Medicines Safety Authority)

brinavess

merck sharp & dohme (new zealand) limited - vernakalant hydrochloride 20 mg/ml equivalent to 18.1 mg/ml of vernakalant - concentrate for infusion - 20 mg/ml - active: vernakalant hydrochloride 20 mg/ml equivalent to 18.1 mg/ml of vernakalant excipient: citric acid monohydrate sodium chloride sodium hydroxide water for injection - rapid conversion of recent onset atrial fibrillation to sinus rhythm in adults · for non-surgery patients: atrial fibrillation less than or equal to 7 days duration · for post-cardiac surgery patients: atrial fibrillation less than or equal to 3 days duration

BRINAVESS 200 mg Infusion South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

brinavess 200 mg infusion

pharmacare limited - infusion - each 1,0 ml solution contains vernakalant hydrochloride 20,0 mg

BRINAVESS 500 mg Infusion South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

brinavess 500 mg infusion

pharmacare limited - infusion - each 1,0 ml solution contains vernakalant hydrochloride 20,0 mg

BRINAVESS® 20mg/ml 500 mg/25 ml Infusion United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

brinavess® 20mg/ml 500 mg/25 ml infusion

city medical store - sole proprietorship l.l.c netherlands - 1 glass vial (25 ml) - infusion - 500 mg/25 ml - cardiovascular system-antiarrythmic

PRINCESS AUTO POWERFOAM C SOLUTION Canada - English - Health Canada

princess auto powerfoam c solution

princess auto ltd. - sodium hypochlorite - solution - 7.20% - sodium hypochlorite 7.20% - disinfectants (for agents used on object)